---
document_datetime: 2023-09-21 18:57:28
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/xermelo-epar-all-authorised-presentations_en.pdf
document_name: xermelo-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 0.7255143
conversion_datetime: 2025-12-24 02:03:23.33898
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging         | Pack size   |
|------------------|-------------------|------------|-----------------------|---------------------------|-----------------------------|-------------|
| EU/1/17/1224/001 | Xermelo           | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/PVC/Alu) | 90 tablets  |
| EU/1/17/1224/002 | Xermelo           | 250 mg     | Film-coated tablet    | Oral use                  | blister (PVC/PCTFE/PVC/Alu) | 180 tablets |